| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07139873 A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6) |
Sponsor changed: Dizal (Jiangsu) Pharmaceutical Co., Ltd. -> Dizal Pharmaceuticals |
| 2026-05-15 | NCT07454863 A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) |
overall status: "Not Yet Recruiting" → "Completed" |
| 2026-05-15 | NCT07454863 A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) |
date change Primary completion moved earlier: 2026-08 -> 2026-03-27 |
| 2026-05-15 | NCT07454863 A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15) |
date change Completion moved earlier: 2026-09 -> 2026-04-06 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07139873 | A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting |
| Phase 2 | |||
| NCT06539182 | DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting |
| NCT06539195 | DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9) | Diffuse Large B Cell Lymphoma | Active, Not Recruiting |